The integration of multi-omics approaches in drug discovery is rapidly gaining momentum, offering a more comprehensive understanding of disease biology and paving the way for personalized medicine. A ...
We compared the TuPro melanoma cohort (n = 98), which received multi-omics–guided selection of adjuvant, standard of care and beyond standard-of-care therapies in patients with advanced melanoma, to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results